A Multicenter, Randomized, Double-blind, Active-controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Ezetimibe/Rosuvastatin+Telmisartan (Primary) ; Ezetimibe/rosuvastatin; Telmisartan
- Indications Essential hypertension; Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Hanlim Pharmaceutical
- 17 Dec 2020 New trial record